A generic alternative indicated for Autoimmune Care and COVID-19. This formulation modulates inflammatory pathways to reduce joint inflammation and immune-mediated tissue damage.
Intended to address overactive immune responses to alleviate rheumatoid arthritis pain and mitigate hair loss in alopecia areata to support long-term disease management.
Mechanism of Action
Baricitinib blocks enzymes called Janus kinases (JAK). These enzymes act as communication hubs within cells, signaling the immune system to create inflammation. By blocking them, it reduces the symptoms of autoimmune diseases.
Route of Administration
Oral
Onset Time
Weeks to months
Duration
24 hours
Contraindications
Severe kidney impairment, Severe liver impairment, Active serious infections, Pregnancy
Information for Olumiant is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
